
We’ll be at the Nordic Metabolomics Conference 2026 in Uppsala to share the data on this question.
Our Product Specialist Cristina and Carmen Ludwig-Papst, PhD, from our partner biocrates will present the poster:
Integrative metabolomic and microbiome profiling identifies candidate biomarkers and pathological mechanisms associated with coronary artery disease
Should you or a colleague be there, this is a great opportunity to learn how metabolome and microbiome interact in CAD.
Please stop by poster 1074 for a closer look at the findings and a conversation about the study.
And if your interests lie elsewhere, they’ll also be happy to discuss your research, current projects, or any questions regarding your workflow and applications.